García-Irizarry, Kimberly D.
Rojas-Brenes, María E.
Oliveras-Torres, José A.
Ortiz-Ortiz, Camila N.
Cress, William D.
Gordián, Edna
Martínez, Ricardo Gómez
Quintana-González, Francisco J.
Escobar-Rodríguez, Pedro F.
Muñoz-Antonia, Teresita
Flores, Idhaliz https://orcid.org/0000-0003-2130-4508
Funding for this research was provided by:
National Cancer Institute (U54 CA163071)
U.S. National Library of Medicine (NU58DP007164)
Article History
Received: 28 May 2024
Revised: 5 December 2024
Accepted: 11 December 2024
First Online: 20 January 2025
Declarations
:
: The study was approved by the Institutional Review Board of the Ponce Research Institute-Ponce Medical School Foundation as an Exempt protocol since data used in this secondary analysis was de-identified.
: Informed consent was obtained from all individual participants included in the Puerto Rico Biobank. This consent allows for analysis of de-identified data in secondary analysis under IRB Exempt protocols.
: The authors have no relevant financial or non-financial interests to disclose.